For example, it can alleviate non-alcoholic fatty liver disease (NAFLD) in mice by regulating Sphingosine 1-phosphate receptor signaling (54, 55). This evidence concerns the gene S1PR1 and metabolic dysfunction-associated steatotic liver disease.